Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: Two case-control studies, Spain, season 2009-2010

BMC Public Health

Volumn 11, Issue , 2011, Pages 1-9

  Savulescu, Camelia ^a,b   Jiménez Jorge, Silvia ^a,k   De Mateo, Salvador ^a,k   Pozo, Francisco ^c   Casas, Inmaculada ^c   Brẽa, Pilar ^c   Galmés, Antonia ^d   Vanrell, Juana M ^d   Rodriguez, Carolina ^e   Vega, Tomas ^e   Martinez, Ana ^e   Torner, Nuria ^e,k   Ramos, Julián M ^f   Serrano, Maria C ^f   Castilla, Jesús ^g,k   Cenoz, Manuel ^g,k   Altzibar, Jone M ^h,k   Arteagoitia, Jose M ⁱ   Quĩones, Carmen ^j   Perucha, Milagros ^j   Larrauri, Amparo ^a,k   more..

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b EPICONCEPT   (France)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d General Department of Public Health Baleares   (Spain)

^e Consejería de Sanidad de Castilla y Leán ^*  (Spain)

^f Public Health Directorate   (Spain)

^g INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^h Gipuzkoa   (Spain)

ⁱ Public Health Service   (Spain)

^j General Department of Public Health and Consumption   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; SPAIN; VIROLOGY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POPULATION SURVEILLANCE; SPAIN; YOUNG ADULT;

EID: 84856087207     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-899     Document Type: Article

References (27)

1. New influenza A(H1N1) virus infections in Spain, April-May 2009. Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain, Euro Surveill 2009 14 http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=19209 pii = 19209
2. European Influenza Surveillance Scheme on the Internet. Snacken R, Manuguerra JC, Taylor P, Methods Inf Med 1998 37 266 70 9787627 (Pubitemid 28450064)
3. Characterisation of swabbing for virological analysis in the Spanish Influenza Sentinel Surveillance System during four influenza seasons in the period 2002-2006. Larrauri A, De Mateo S, Euro Surveill 2007 12 http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=706 pii = 706
4. European Influenza Surveillance Network (EISN). European Centre for Disease Prevention and Control (ECDC), http://ecdc.europa.eu/en/activities/ surveillance/EISN/Pages/home.aspx
5. Recommendations for influenza vaccination in the season 2009-10. Ministry of Health and Social Policy, Spain, http://www.msc.es/ciudadanos/enfLesiones/ enfTransmisibles/gripe/gripe.htm#prevencion [In Spanish]
6. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain. Larrauri A, Savulescu C, Jiménez-Jorge S, Pérez-Brẽa P, Pozo F, Casas I, Ledesma J, de Mateo S, the Spanish Influenza Surveillance System (SISS), Gac Sanit 2011 25 1 23 8 10.1016/j.gaceta.2010.06.010 21334788
7. Recommendations for Influenza Vaccines Composition. Northern hemisphere: 2009-2010. World Health Organization (WHO), http://www.who.int/influenza/ vaccines/vaccinerecommendations1/en/index1.html
8. Recommended composition of influenza virus vaccines for use in the 2010 influenza season-full report. World Health Organization (WHO), http://www.who.int/csr/don/2009-09-25/en/
9. Vaccination campaign for the pandemic influenza virus H1N1 2009-Official recommendations. Ministry of Health and Health Policies, Spain, http://www.aemps.gob.es [In Spanish]
10. Influenza Vaccine Effectiveness Working Group. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Valenciano M, Ciancio B, Moren A, Euro Surveill 2008 13 1 8 http://www.eurosurveillance.org/images/dynamic/EE/V13N43/ art19015.pdf
11. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups, 2008-2009 season, Spain. Savulescu C, Valenciano M, Mateo S, Larrauri A, the cycEVA Study Team, Vaccine 2010 28 2903 07 10.1016/j.vaccine.2010.01.054 20153351
12. Estimation of influenza vaccine effectiveness from routine surveillance data. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I, PLoS One 2009 4 1 7 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658741/pdf/pone.0005079.pdf 10.1371/journal.pone.0005361
13. Estimating Influenza vaccine effectiveness using routinely collected laboratory data. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, Miller E, Zambon M, J Epidemiol Community Health 2010 64 1062 67 http://jech.bmj.com/content/64/12/1062.full.pdf 10.1136/jech.2009.093450 19910645
14. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G, Vaccine 2007 25 2842 51 10.1016/j.vaccine.2006.10.002 17081662 (Pubitemid 46412567)
15. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK, J Infect Dis 2009 199 159 67 http://www.journals.uchicago.edu/doi/pdf/10.1086/ 595861 10.1086/595861 19086915
16. Component-specific effectiveness of the trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. Skowronski DM, De Serres G, Dickenson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y, J Infect Dis 2009 199 168 79 http://www.journals.uchicago.edu/doi/pdf/10.1086/595862 10.1086/595862 19086914
17. Commission Decision 2009/363/EC of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. European Commission, OJ L 58 http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=OJ:L:2009:110:0058:0059:EN:PDF 110, 1.5.208
18. Protocol for case-control studies to measure pandemic and seasonal influenza vaccine effectiveness in the European Union and European Economic Area Member States. European Centre for Disease Prevention and Control (ECDC), http://www.ecdc.europa.eu/en/publications/Publications/0907-TED-Influenza-AH1N1- Measuring-Influenza-Vaccine-Effectiveness-Protocol-Case-Control-Studies.pdf Technical document
19. Pandemic vaccination coverage 2009-2010. Ministry of Health and Social Policy, Spain, http://www.mspsi.es/profesionales/saludPublica/prevPromocion/ vacunaciones/coberturas.htm [In Spanish]
20. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Wichmann O, Stocker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, Krause G, Eckmanns T, Euro Surveill 2010 15 http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19561 pii = 19561
21. Vaccine effectiveness in pandemic influenza-primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J, Health Technol Assess 2010 14 313 46 http://www.hta.ac.uk/fullmono/ mon1434.pdf 20630126
22. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellán, Spain. A test-negative, hospital-based, case-control study. Puig-Barberá J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, Safont-Adsuara L, Ruiz-García M, The Members of the Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellán (Spain), Vaccine 2010 28 7460 7 10.1016/j.vaccine.2010.09.042 20875486
23. Effectiveness of pandemic and seasonal influenza vaccine in reventing pandemic influenza A (H1N1)2009 infection in England and Scotland 2009-2010. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, Pebody RG, Euro Surveill 2011 16 http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763 pii = 19763
24. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M, BMJ 2011 342 http://www.bmj.com/content/342/bmj.c7297
25. Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A, PLoS Med 2011 8 http://www.plosmedicine.org/article/info: doi/10.1371/journal.pmed.1000388
26. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Valenciano M, Kissling E, Ciancio BC, Moren A, Vaccine 2010 28 7381 8 10.1016/j.vaccine.2010.09.010 20851086
27. European Health for All Database. World Health Organization (WHO), Regional Office for Europe, http://data.euro.who.int/hfadb/ accessed on 22 October 2010